CAPR vs CRMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRMD Captures Institutional Edge (2โ2 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin while CAPR counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, CAPR trades at 78.7x Forward P/E with 0.0% operating margin (-7.9% YoY revenue) versus CRMD at 49.0x Forward P/E and 41.0% operating margin (-47.7% YoY). In options structure, CAPR sits in CONSOLIDATION (89th %ile IV; Dealer Gamma Walls on Pro) against CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAPR Revenue | CRMD Revenue | CAPR Op. Margin | CRMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $0M | -917.0% | -6250.4% | CAPR |
| FY2019 | $0M | $0M | -769.5% | -7416.3% | CAPR |
| FY2020 | $0M | $0M | -4412.6% | -11378.4% | CAPR |
| FY2021 | $0M | $0M | -8549.9% | -15417.5% | CAPR |
| FY2022 | $0M | $0M | -1163.9% | -46819.9% | CAPR |
| FY2023 | $30M | N/A | -95.6% | N/A | CAPR |
| FY2024 | $20M | $40M | -191.1% | -51.4% | CRMD |
| FY2025 | N/A | $310M | N/A | 48.2% | CRMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAPR | CRMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $595.4M | $384.7M | Larger Scale | CAPR |
| Trailing P/E Ratio Valuation | 78.7x | 2.4x | Lower Multiple | CRMD |
| Forward P/E Ratio Valuation | 78.7x | 49.0x | Lower Multiple | CRMD |
| Revenue Growth (YoY) Growth | -7.9% | -47.7% | Higher Growth | CAPR |
| Operating Margin (TTM) Profitability | 0.0% | 41.0% | Higher Margin | CRMD |
| Net Profit Margin Profitability | 0.0% | 15.5% | Higher Margin | CRMD |
| Return on Equity (ROE) Capital Efficiency | -100.5% | 15.3% | Higher ROE | CRMD |
| 52-Week Range Position Momentum | 15% ($3โ$40) | 3% ($5โ$13) | Stronger Trend | CAPR |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 152% Vol | 1.20ฮฒ ยท 107% Vol | Lower Realized Risk | CRMD |
| Unified Institutional Score Composite Signal | 28.0 / 100 (SELL) | 53.2 / 100 (HOLD) | Higher Composite | CRMD |